Stocks to sell

I have always wondered about why the memesters decided they liked Clover Health (NASDAQ:CLOV) stock. Source: Shutterstock Maybe it was the short squeeze, which came after Hindenburg Research issued a February report calling the business broken. Maybe it was Chamath Palihapitiya, whom I have likened to Prof. Harold Hill of The Music Man. (Full disclosure:
0 Comments
It hasn’t been a fun ride for Workhorse (NASDAQ:WHKS) stock. Source: rblfmr / Shutterstock.com In fact, most start-up EV, low-quality special purpose acquisition companies (SPACs) and high-growth stocks have struggled over the past few months. In the case of WKHS stock, shares remain 76% below the all-time high set in February. Unfortunately for Workhorse, earnings aren’t
0 Comments
Clover Health Investments (NASDAQ:CLOV) recently reported second quarter revenue and earnings on Aug 11. The numbers showed a huge gain in revenue but an equally huge increase in its losses. This does not bode well for CLOV stock. Source: Shutterstock Additionally, Clover significantly raised its total 2021 revenue outlook from $820 million at the midpoint last quarter
0 Comments
For a short while at the start of summer, ContextLogic (NASDAQ:WISH) stock looked as though it would erase its post-initial public offering slump. Source: sdx15 / Shutterstock.com Reddit’s r/WallStreetBets subgroup liked WISH stock for its ticker name and nothing more. Speculators bet that the e-commerce site would become the next Amazon.com (NASDAQ:AMZN). Without a moat
0 Comments
Seemingly out of nowhere, presidential and mayoral candidate Andrew Yang brought to the mainstream several ideas that absolutely needed to be talked about, one of them being data as the current century’s gold or oil. Since data is so valuable, it can theoretically fund multiple initiatives. For Palantir Technologies (NYSE:PLTR), that sounds just about right.
0 Comments
Senseonics Holdings (NYSEAMERICAN:SENS) develops medical technology, including “continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa.” The company’s product line includes implantable CGM systems that go under the user’s skin and a removable, rechargeable transmitter that works with an app made by the company. SENS
0 Comments
Exela Technologies (NASDAQ:XELA) is a business process automation (BPA) leader utilizing industry specific and multi industry enterprise software and solutions. The company’s products and solutions are deployed in banking, healthcare, insurance and other industries. The XELA stock price has pulled back about 18% from its mid-July three-month high. Source: Shutterstock The Covid-related work from home
0 Comments